Further Data Against the Use of Cyproterone Acetate in Gender-Affirming Hormone Therapy Regimens

• by Daniel J Slack, Joshua D Safer

• October 16, 2024

Visceral adipose tissue and liver fat on 17-beta estradiol-dominant gender-affirming hormone therapy: A US-based cohort

• by Ria Talathi, Vencel Juhasz, Matilda Delgado, Thiago Quinaglia, Azin Ghamari, Melissa Wang, Iad Alhallak, Sarah Stinebaugh, Sophia Campbell, Sara L Stockman, Mustafa A Ozturk, Sadia M Ahmadi, Sara E Looby, Hang Lee, Tonia C Poteat, Lidia S Szczepaniak, Markella V Zanni, Tomas G Neilan, Mabel Toribio

• December 12, 2025

Effects of ambient air pollutants and environmental greenness on the incidence of pre-/hypertension in children and adolescents

• by Maike Wolters, Rajini Nagrani, Nour Naaouf, Stefaan De Henauw, Lauren Lissner, Luis A Moreno, Dénes Molnár, Paola Russo, Tanja Vrijkotte, Wolfgang Ahrens, Claudia Börnhorst, on behalf of the IDEFICS/I.Family consortium

• September 23, 2025

Mandatory Training Modules Deserve a Harder Look

A JAMA Viewpoint argues that 4 million physician-hours spent on compliance modules each year warrants institutional reassessment.

• by Kerri Miller

• April 16, 2026

• 3 min